Zelira Therapeutics Ltd (FRA:G1G)
€ 0.464 0.01 (2.2%) Market Cap: 5.64 Mil Enterprise Value: 6.68 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 25/100

Zelira Therapeutics Ltd Annual Shareholders Meeting Transcript

Apr 12, 2022 / 01:00AM GMT
Release Date Price: €1.58
Osagie Imasogie
Zelira Therapeutics Limited - Chairman

It is now 9:00 AM. I am delighted to welcome all shareholders and observers to this general meeting of Zelira Therapeutics Limited. For those that don't know me, I am Osagie Imasogie, Zelira's Chairman.

The other directors present virtually today are Harry Karelis, our Vice Chairman; Oludare Odumosu, our CEO and Managing Director; Lisa Gray, our Non-Executive Director; and Tim Slate, our Non-Executive Director and Company Secretary.

I will ask all those present to note that the shareholders' register is available for inspection and that the proxies affecting today's resolutions are tabled and available for inspection. There is a quorum present, and I declare the meeting open.

Today's meeting is being held online via the Computershare meeting platform. This allows shareholders, proxies, and guests to attend the meeting virtually. All attendees can watch a live webcast of the meeting.

In addition, shareholders and proxies have the ability to ask questions and submit votes. All our attendees can submit questions at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot